World's Best Scientists 2026 revealed!
William L. Carroll

William L. Carroll

D-Index & Metrics

Medicine

D-Index
102
Citations
40625
World Ranking
7626
National Ranking
3971

Research.com Recognitions

  • 2020 - Fellow of the Royal Society of Canada Academy of Social Sciences
  • 1934 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

William L. Carroll is affiliated with New York University in the United States and has a primary research focus in Medicine. Their scholarly contributions span several subfields, including Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health, Hematology, Genetics, and Molecular Biology.

The scientist's research encompasses critical topics such as Acute Lymphoblastic Leukemia research, Childhood Cancer Survivors' Quality of Life, Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, and Lung Cancer Research Studies.

Notable recent publications include:

  • "The genomic landscape of pediatric acute lymphoblastic leukemia," 2022, Nature Genetics
  • "Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia," 2020, Journal of Clinical Oncology
  • "Extensive Remodeling of the Immune Microenvironment in B Cell Acute Lymphoblastic Leukemia," 2020, Cancer Cell
  • "Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group," 2020, Journal of Clinical Oncology
  • "An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia," 2022, Nature Cancer

Frequent co-authors contributing to their research efforts include:

  • Elizabeth A. Raetz
  • Mignon L. Loh
  • Meenakshi Devidas
  • Stephen P. Hunger
  • Naomi Winick

William L. Carroll has published extensively in several scientific venues. The most frequent publication outlets include:

  • Blood
  • Journal of Clinical Oncology
  • Leukemia
  • Pediatric Blood & Cancer
  • Blood Advances

In addition to journal articles, there is a record of book publication with Columbia University Press, including a title published in 2022.

Their work has been recognized with several professional honors. These include being named a Fellow of the Royal Society of Canada in 2020, attributed to the Academy of Social Sciences, and being elected as a Fellow of the American Association for the Advancement of Science (AAAS) in 1934. They are also a member of the Association of American Physicians.

Best Publications

  • Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

    Charles G Mullighan;Xiaoping Su;Jinghui Zhang;Ina Radtke

  • Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia

    K. G. Roberts;Y. Li;D. Payne-Turner;R. C. Harvey

  • Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group

    Stephen P. Hunger;Xiaomin Lu;Meenakshi Devidas;Bruce M. Camitta

  • Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update

    Ching Hon Pui;William L. Carroll;Soheil Meshinchi;Robert J. Arceci

  • The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia

    Yu Liu;John Easton;Ying Shao;Jamie Maciaszek

  • Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.

    Michael J. Borowitz;Meenakshi Devidas;Stephen P. Hunger;W. Paul Bowman;W. Paul Bowman

  • Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

    Jyoti D. Patel;Lada Krilov;Sylvia Adams;Carol Aghajanian

  • Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia

    Kathryn G. Roberts;Ryan D. Morin;Jinghui Zhang;Martin Hirst

  • Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

    Kirk R. Schultz;W. Paul Bowman;Alexander Aledo;William B. Slayton

  • Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia

    Richard C. Harvey;Richard C. Harvey;Charles G. Mullighan;I-Ming Chen;I-Ming Chen;Walker Wharton

  • JAK mutations in high-risk childhood acute lymphoblastic leukemia.

    Charles G. Mullighan;Jinghui Zhang;Richard C. Harvey;J. Racquel Collins-Underwood

  • Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia.

    Charles G Mullighan;J Racquel Collins-Underwood;Letha A A Phillips;Michael G Loudin

  • Factors Influencing Survival After Relapse From Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

    Kim Nguyen;Meenakshi Devidas;Su-Chun Cheng;Mei La

  • Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)

    Kirk R. Schultz;D. Jeanette Pullen;Harland N. Sather;Jonathan J. Shuster

  • Germline genomic variants associated with childhood acute lymphoblastic leukemia.

    Lisa R Treviño;Wenjian Yang;Deborah French;Stephen P Hunger

  • Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.

    Richard C. Harvey;Richard C. Harvey;Charles G. Mullighan;Xuefei Wang;Kevin K. Dobbin

  • Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031.

    K. R. Schultz;A. Carroll;N. A. Heerema;W. P. Bowman

  • PAX5 -driven subtypes of B-progenitor acute lymphoblastic leukemia

    Zhaohui Gu;Michelle L. Churchman;Kathryn G. Roberts;Ian Moore

  • Gene expression profiling. Methods and clinical applications in oncology.

    Elizabeth A. Raetz;Philip J. Moos;Aniko Szabo;William L. Carroll

  • Rearrangement of CRLF2 in B-Progenitor and Down Syndrome Associated Acute Lymphoblastic Leukemia.

    Charles G. Mullighan;J. Racquel Collins-Underwood;Letha A Phillips;Michael G. Loudin

Frequent Co-Authors

Stephen P. Hunger
Stephen P. Hunger University of Pennsylvania
Meenakshi Devidas
Meenakshi Devidas St. Jude Children's Research Hospital
Elizabeth A. Raetz
Elizabeth A. Raetz New York University
Naomi J. Winick
Naomi J. Winick The University of Texas Southwestern Medical Center
Mignon L. Loh
Mignon L. Loh University of California, San Francisco
Cheryl L. Willman
Cheryl L. Willman University of New Mexico
Michael J. Borowitz
Michael J. Borowitz Johns Hopkins University
Nyla A. Heerema
Nyla A. Heerema The Ohio State University
Brent L. Wood
Brent L. Wood University of Washington
Mary V. Relling
Mary V. Relling St. Jude Children's Research Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While many international students dream of studying Medicine in the USA, there are also flexible online degree options in healthcare that can lead to rewarding careers. For registered nurses looking to advance their education without breaking the bank, exploring the cheapest bsn programs is a smart first step. These programs allow working nurses to earn a bachelor's degree online at a lower cost.

Those who already hold a bachelor's degree in another field but want to switch to nursing may consider online direct entry msn programs for non-nurses. These accelerated options fast-track non-nurses into the profession, often combining RN and master’s level coursework.

If you’re just beginning your path in healthcare, you may want to look into adn programs, which provide a two-year route to becoming a registered nurse. For those with advanced ambitions, pursuing an online phd in nursing can open doors to leadership, teaching, and research roles.

Each pathway offers unique benefits and entry points into healthcare careers, making it easier than ever to pursue your passion for medicine and patient care.

Best Scientists Citing William L. Carroll

Trending Scientists

Recently Published Articles